BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 8553077)

  • 21. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
    Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-89-S12-95. PubMed ID: 9331129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary results of a phase I study of weekly paclitaxel infusion in patients with non-small cell lung cancer.
    Akerley W; Glantz M; Choy H
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):14-8. PubMed ID: 8941405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-hour paclitaxel in the treatment of non-small cell lung cancer.
    Hainsworth JD; Greco FA
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):98-101. PubMed ID: 9007133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of patients with metastatic nonsmall cell carcinoma of the lung treated with paclitaxel by 3-hour infusion.
    Tester WJ; Jin PY; Reardon DH; Cohn JB; Cohen MH
    Cancer; 1997 Feb; 79(4):724-9. PubMed ID: 9024710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel (1-hour infusion) plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicenter phase II trial.
    Greco FA; Hainsworth JD
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-14-S12-17. PubMed ID: 9331113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The activity of paclitaxel in gastrointestinal tumors.
    Ajani JA; Ilson DH; Kelsen DP
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):46-50; discussion 51-3. PubMed ID: 7481861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-escalation study of weekly 1-hour paclitaxel administration in patients with refractory cancer.
    Chang AY; Boros L; Asbury R; Hui L; Rubins J
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-69-S17-71. PubMed ID: 9374098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel and simultaneous radiation in the treatment of stage III A/B non-small cell lung cancer.
    Havemann K; Wolf M; Goerg C; Faoro C; Pfab R; Diergarten K
    Semin Oncol; 1995 Dec; 22(6 Suppl 14):19-22. PubMed ID: 8553078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paclitaxel by either 1-hour or 24-hour infusion in combination with carboplatin in advanced non-small cell lung cancer: preliminary results comparing sequential phase II trials.
    DeVore RF; Jagasia M; Johnson DH
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-27-S12-29. PubMed ID: 9331116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel and carboplatin in nonoperable non-small cell lung cancer.
    Kosmidis P; Mylonakis N; Fountzilas G; Samantas E; Athanasiadis A; Skarlos D
    Semin Oncol; 1996 Dec; 23(6 Suppl 15):16-8. PubMed ID: 8996591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weekly paclitaxel in patients with advanced lung cancer: preliminary data from a phase II trial.
    Akerley W; Choy H; Safran H; Sikov W; Rege V; Sambandam S; Wittels E
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-10-S12-13. PubMed ID: 9331112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary results of a phase I/II clinical trial of paclitaxel and carboplatin in non-small cell lung cancer.
    Natale RB
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):51-4. PubMed ID: 9007122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-agent paclitaxel in the treatment of advanced non-small cell lung cancer.
    Socinski MA
    Oncologist; 1999; 4(5):408-16. PubMed ID: 10551557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paclitaxel and cisplatin in patients with non-small cell lung cancer: results of a phase II trial.
    von Pawel J; Wagner H; Niederle N; Heider A; Koschel G; Gromotka E; Hanske M
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):7-9. PubMed ID: 8941403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
    Edelman MJ; Meyers FJ; Houston J; Lauder I
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel in the treatment of carcinoma of the esophagus.
    Ajani JA; Ilson DH; Daugherty K; Kelsen DP
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):35-40. PubMed ID: 7541155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer.
    Choy H; Safran H; Akerley W; Graziano SL; Bogart JA; Cole BF
    Clin Cancer Res; 1998 Aug; 4(8):1931-6. PubMed ID: 9717821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.